Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Acta Neurologica Belgica
|
June 20, 2019
Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis
Anke Wouters, Ide Smets, Wim Van den Noortgate, et al.
Scientific Reports
|
January 16, 2021
Quantitative MRI phenotypes capture biological heterogeneity in multiple sclerosis patients
Ide Smets, An Goris, Marijne Vandebergh, et al.
European Journal of Neurology
|
May 26, 2022
The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosis
Ashok Adams, William Tilden, Jonathan Bestwick, et al.
Multiple Sclerosis and Related Disorders
|
November 9, 2023
Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model
Cato E A Corsten, Simone A Huygens, Matthijs M Versteegh, et al.
Annals of Neurology
|
January 31, 2020
CHIT1 at Diagnosis Reflects Long-Term Multiple Sclerosis Disease Activity
Emanuela Oldoni, Ide Smets, Klara Mallants, et al.
Multiple Sclerosis and Related Disorders
|
April 8, 2026
Optical coherence tomography intereye difference metrics to detect optic nerve lesions in children with inflammatory demyelinating disease
Michiel S J Buijze, Sandy Molenaar, Ide Smets, et al.
Frontiers in Immunology
|
June 14, 2021
Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis
Ide Smets, Teresa Prezzemolo, Maya Imbrechts, et al.
European Journal of Immunology
|
July 14, 2018
IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways
Maya Imbrechts, Karen De Samblancx, Karlien Fierens, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 23, 2020
CSF neurofilament light chain testing as an aid to determine treatment strategies in MS
Saúl Reyes, Ide Smets, David Holden, et al.
Multiple Sclerosis and Related Disorders
|
March 8, 2026
Genetic and environmental mediators of multiple sclerosis susceptibility but not early severity run in families
Cato E A Corsten, Ana M Marques, Yifan van Hasselt, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Acta Neurologica Belgica
|
June 20, 2019
Cerebrovascular events after surgery versus conservative therapy for moyamoya disease: a meta-analysis
Anke Wouters, Ide Smets, Wim Van den Noortgate, et al.
Scientific Reports
|
January 16, 2021
Quantitative MRI phenotypes capture biological heterogeneity in multiple sclerosis patients
Ide Smets, An Goris, Marijne Vandebergh, et al.
European Journal of Neurology
|
May 26, 2022
The relationship of cerebrospinal fluid neurofilament levels with magnetic resonance imaging lesion location and disease activity in multiple sclerosis
Ashok Adams, William Tilden, Jonathan Bestwick, et al.
Multiple Sclerosis and Related Disorders
|
November 9, 2023
Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model
Cato E A Corsten, Simone A Huygens, Matthijs M Versteegh, et al.
Annals of Neurology
|
January 31, 2020
CHIT1 at Diagnosis Reflects Long-Term Multiple Sclerosis Disease Activity
Emanuela Oldoni, Ide Smets, Klara Mallants, et al.
Multiple Sclerosis and Related Disorders
|
April 8, 2026
Optical coherence tomography intereye difference metrics to detect optic nerve lesions in children with inflammatory demyelinating disease
Michiel S J Buijze, Sandy Molenaar, Ide Smets, et al.
Frontiers in Immunology
|
June 14, 2021
Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis
Ide Smets, Teresa Prezzemolo, Maya Imbrechts, et al.
European Journal of Immunology
|
July 14, 2018
IFN-γ stimulates CpG-induced IL-10 production in B cells via p38 and JNK signalling pathways
Maya Imbrechts, Karen De Samblancx, Karlien Fierens, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 23, 2020
CSF neurofilament light chain testing as an aid to determine treatment strategies in MS
Saúl Reyes, Ide Smets, David Holden, et al.
Multiple Sclerosis and Related Disorders
|
March 8, 2026
Genetic and environmental mediators of multiple sclerosis susceptibility but not early severity run in families
Cato E A Corsten, Ana M Marques, Yifan van Hasselt, et al.
Page
of 3